Your browser doesn't support javascript.
loading
COVID-19 post-vaccination in healthcare workers and vaccine effectiveness, Brazil, 2021
Fernandes, Caio Medeiros; Dias, Shirley L.; Ferreira, Maira C.; Luna, Expedito J.A..
Afiliação
  • Fernandes, Caio Medeiros; Universidade de São Paulo (HCFMUSP). Faculdade de Medicina. Hospital das Clínicas. São Paulo. BR
  • Dias, Shirley L.; Universidade de São Paulo (HCFMUSP). Faculdade de Medicina. Hospital das Clínicas. São Paulo. BR
  • Ferreira, Maira C.; Universidade de São Paulo (HCFMUSP). Faculdade de Medicina. Hospital das Clínicas. São Paulo. BR
  • Luna, Expedito J.A.; Universidade de São Paulo (HCFMUSP). Faculdade de Medicina. Hospital das Clínicas. São Paulo. BR
Clinics ; 77: 100109, 2022. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1404308
Biblioteca responsável: BR1.1
ABSTRACT
Abstract Objects This study aimed to describe COVID-19 cases in healthcare workers at a large tertiary hospital, after a vaccination campaign, to understand the individual characteristics, timeliness, symptomatology, and severity of the conditions.

Methods:

The COVID-19 reporting files from the hospital's healthcare workers and their records in the vaccine registry were analyzed, regarding vaccination status, symptoms, sociodemographic characteristics, comorbidities, and outcomes. Vaccination descriptive analysis was carried out and the impact and effectiveness of vaccination in relation to symptomatic infection and hospitalization were estimated.

Results:

In a total of 696 PCR-confirmed COVID-19 patients, vaccination coverage for the 1st and 2nd dose was 92.8% and 85.5%. Patients with complete doses had a mean interval of 96.8 days between vaccination and the onset of symptoms. Of the 664 participants with available clinical data, 165 had at least 1 comorbidity. During the study, 12 patients were hospitalized, 58.3% with a complete vaccination schedule. Three of this group died. The effectiveness of vaccination for symptomatic cases and hospitalization was 22.1% and 69.0%, respectively. The impact of vaccination on symptomatic cases and hospitalization was 81.4% and 89.7%, respectively.

Discussion:

The majority of COVID-19 cases in the study were classified as mild. The impact of vaccination for confirmed cases was significant, both in reducing the incidence of symptomatic cases and hospitalizations. The presence of comorbidities in approximately » of the patients increased the risk of these individuals. The mean time interval between diagnosis and the 2nd dose of vaccine was longer in the hospitalized group, reinforcing the protective decline over longer periods.


Texto completo: Disponível Coleções: Bases de dados internacionais Contexto em Saúde: Agenda de Saúde Sustentável para as Américas Problema de saúde: Objetivo 3: Recursos humanos em saúde Base de dados: LILACS Tipo de estudo: Estudo de avaliação País/Região como assunto: América do Sul / Brasil Idioma: Inglês Revista: Clinics Assunto da revista: Medicina Ano de publicação: 2022 Tipo de documento: Artigo País de afiliação: Brasil Instituição/País de afiliação: Universidade de São Paulo (HCFMUSP)/BR

Texto completo: Disponível Coleções: Bases de dados internacionais Contexto em Saúde: Agenda de Saúde Sustentável para as Américas Problema de saúde: Objetivo 3: Recursos humanos em saúde Base de dados: LILACS Tipo de estudo: Estudo de avaliação País/Região como assunto: América do Sul / Brasil Idioma: Inglês Revista: Clinics Assunto da revista: Medicina Ano de publicação: 2022 Tipo de documento: Artigo País de afiliação: Brasil Instituição/País de afiliação: Universidade de São Paulo (HCFMUSP)/BR
...